Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2015 / Articles / Feb / Power to the People
Business & Regulation Business Practice Trends & Forecasts

Power to the People

Who are the top 100 most influential people in drug development and manufacturing today? That’s the question we’re aiming to answer with The Power List 2015. But we need your help…

By Charlotte Barker 02/02/2015 1 min read

Share

Why list the Top 100? First and foremost, we want to celebrate your achievements, your passion and your pride in your work. You are a fascinating, diverse, brilliant and self-effacing community – your work brings therapies to patients around the world, and we want to put you center stage.

We have seen tremendous progress in recent years. In just this single issue of the magazine, you can see advances in every aspect of drug development and manufacture - from formulation strategies to bring even the most intractable molecules to market, to the development of cell factories for cleaner, greener manufacturing, to ever-increasing safety and efficiency standards. We want to recognize the people who have made all this possible, and who continue to push the field forward every day. To help us compile this list of the great and good, we want to know who has influenced you. Perhaps it is their groundbreaking research, or their generosity in sharing their knowledge with colleagues. It might be their leadership and business acumen, their commitment to raising standards, or their ability to unite the field behind a common cause. Who are the thought leaders, the opinion shapers and the unsung heroes of the industry?

Of course, we expect to see plenty of senior executives on the list, but we want to throw open the door to academics, regulators, consultants and philanthropists too. We welcome nominations from small molecule and biologic sectors, originator and generic, pharma, biotech and contract organizations, from all four corners of the globe and from any discipline. Have your say on who appears on what we anticipate will be a hotly debated and contested list!

You can nominate as many people as you like – nominate yourself, a colleague or a hero of your field. Fill in the short nomination form or drop me a line at charlotte.barker@texerepublishing.com. Nominations will be reviewed by a panel of judges, who will be responsible for choosing the final 100.

Help us celebrate the people who are pushing the field forward in The Medicine Maker Power List 2015.

Charlotte Barker
Editor

charlotte barker signature

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Charlotte Barker

As an Editor at Texere, I’m working closely with our audience to create vibrant, engaging content that reflects the hard work and passion that goes into bringing new medicines to market. I got my start in biomedical publishing as a commissioning editor for healthcare journals and have spent my career covering everything from early-stage research to clinical medicine, so I know my way around. And I can’t think of a more interesting, challenging or important area to be working in.

More Articles by Charlotte Barker

False

Advertisement

Recommended

False

Related Content

What Trump’s Latest Moves Mean for the Industry
Business Practice Standards & Regulation Trends & Forecasts Bioprocessing - Upstream & Downstream
What Trump’s Latest Moves Mean for the Industry

May 27, 2025

6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

Big Bad Pharma?
Business Practice Trends & Forecasts
Big Bad Pharma?

December 1, 2014

0 min read

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Access All Areas
Business Practice Trends & Forecasts
Access All Areas

December 1, 2014

0 min read

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

Care to ‘Patent Dance’?
Business Practice Trends & Forecasts
Care to ‘Patent Dance’?

December 1, 2014

0 min read

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.